Skip to main content

Sjogren’s Syndrome

  • Reference work entry
  • First Online:
Geriatric Diseases

Abstract

The syndrome may present alone (primary) or in association with an underlying connective tissue disorder (secondary). In elderly people Sjogren’s syndrome (SS) is subclinical, relatively common and benign. In the elderly Sjogren’s syndrome should be considered when sicca symptoms occur with systemic manifestations. Approximately 40% of xerostomia in the elderly is due to Sjorgren’s syndrome and accounts up to 20% of Sjorgren’s syndrome; arthralgias, Raynaud’s phenomenon and purpura were common extraglandular manifestations. It is important to distinguish age-related gland pathology, drug-induced ocular and oral dryness from that due to SS.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 379.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Miller AV. Sjogren Syndrome Clinical Presentation. Medscape. http://emedicine.medscape.com/article/332125-clinical accessed on 11 September 2015.

  2. Garcia-Carrasco M, Ramos-Casais M, Rosas J, Pallaras L, Calvo-Alen J, Cervera R, et al. Primary Sjogren’s syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270–280.

    Article  PubMed  Google Scholar 

  3. Gentric-Tilly A.Sjogren’s syndrome in the elderly. Ann Med Interne (Paris). 2002;153(6):378–82.

    PubMed  Google Scholar 

  4. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjogren’s syndrome. Nat Clin Pract Rheumatol. 2006;2(5):252–61.

    Article  CAS  PubMed  Google Scholar 

  5. Hashimi AC. Xerostomia secondary to Sjorgren’s syndrome in the elderly: recognition and management. Drugs Aging. 2005;22(11):887–889.

    Article  Google Scholar 

  6. Botsios C, Furlan A, Oatuni P, Sfriso P, Andretta M, Ometto F, et al. Elderly onset of primary Sjogren’s syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine. 2011;78(2):171–4.

    Article  PubMed  Google Scholar 

  7. Drosos AA, Andonpoulos AP, Costopoulos JS, Papadimitrio CS, Moutsopoulos HM. Prevalence of primary Sjogren’s syndrome in an elderly population. Rheumatology. 1988;27(27):123–127.

    Article  CAS  Google Scholar 

  8. Garcia-Carrasco M, Fuentes-Alexandro S, Escarcega RO, Salgado G, Riebeling C, Cervera R. Pathophysiology of Sjogren’s syndrome. Arch Med Res. 2006;37(8);921–32.

    Article  CAS  PubMed  Google Scholar 

  9. Moerman RV, Bootsma H, Kroese FG, Vissink A. Sjogren’s syndrome in older patients: aetiology, diagnosis and management. Drugs Aging. 2013;30(3):137–53.

    Article  CAS  PubMed  Google Scholar 

  10. Kruszka P, O’Brian RJ. Diagnosis and management of Sjogren’s syndrome. Am Fam Physician. 2009;79(6):465–470.

    PubMed  Google Scholar 

  11. Vitali C, Bombadieri S, Jonsson S, Moutsopoulos HM, Alexander EL, Carsons SS, et al. for the European Study Group on Classification Criteria for Sjogren’s syndrome. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–558.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Yung RL, Francis S. Sjogren’s syndrome in the elderly. Chapter Geriatric Rheumatology.pp 287–291. http://link.springer.com/chapter/10.1007%2E978-1-4419-5792-4_29 accessed 11 September, 2015.

  13. Tsifetaki N, Kitsos G, Paschides CA, Alamanos Y, Eftaxias V, Voulgari PV, et al. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren’s syndrome: a randomized 12 week controlled study. Ann Rheum Dis. 2003;62(12):1204–1207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ono M, Takamura E, Shinozaki K, Tsumura T, Hamano T, Yagi Y, et al. Therapeutic effect of cevimeline on dry eye in patients with Sjogren’s syndrome: a randomized, double-blind clinical study. Am J Ophthamol. 2004;138(1):6–17.

    Article  CAS  Google Scholar 

  15. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren’s syndrome. Arch Intern Med. 2004;164(12):1275–1284.

    Article  PubMed  Google Scholar 

  16. Ramos-Cassais M, Tzioufas AG, Font J. Primary sjogren’s syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005;64(3):347–354.

    Article  Google Scholar 

  17. Fox RI, Stern M. Sjogren’s syndrome: mechanisms of pathogenesis involve interaction of immune and neurosensory systems. Scand J Rheumatol Suppl. 2002;116:3–13.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Nagaratnam, N., Nagaratnam, K., Cheuk, G. (2018). Sjogren’s Syndrome. In: Geriatric Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-33434-9_64

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33434-9_64

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33433-2

  • Online ISBN: 978-3-319-33434-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics